Back to Search
CATHERINE VAN POZNAK, MD
MD
Medical Oncology Physician
NPI: 1225109242IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
4301087100(MI)
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
4301087100(MI)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
4301087100(MI)
Education
JS WEILL MEDICAL COLLEGE, CORNELL UNIVERSITY
Class of 1995
Research & Publications (20)
Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates.
PMID 16986349·Oncology (Williston Park)·2006
6-review
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
PMID 16394281·J Clin Pathol·2006
8-other
ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.
PMID 19608765·Genes Dev·2009
7-preclinical
NCCN Task Force Report: Bone Health in Cancer Care.
PMID 19555589·J Natl Compr Canc Netw·2009
6-review
Cancer therapy and osteoporosis: approach to evaluation and management.
PMID 19027468·Semin Oncol·2008
6-review
The heat shock protein 90 chaperone complex: an evolving therapeutic target.
PMID 18781898·Curr Cancer Drug Targets·2008
6-review
Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
PMID 18695259·Oncologist·2008
8-other
Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment.
PMID 18486811·J Oral Maxillofac Surg·2008
8-other
Significance and impact of bisphosphonate-induced acute phase responses.
PMID 18045781·J Oncol Pharm Pract·2007
6-review
Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research.
PMID 17663640·J Bone Miner Res·2007
7-preclinical
Bisphosphonates for breast cancer: questions answered, questions remaining.
PMID 17512453·Hematol Oncol Clin North Am·2007
6-review
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer.
PMID 17200358·Clin Cancer Res·2007
3-trial
Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
PMID 16985239·J Natl Cancer Inst·2006
8-other
C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.
PMID 16959612·Cancer Cell·2006
7-preclinical
Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
PMID 16776787·J Am Geriatr Soc·2006
4-observational
NCCN Task Force Report: Bone Health and Cancer Care.
PMID 16737674·J Natl Compr Canc Netw·2006
7-preclinical
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
PMID 16541322·Breast Cancer Res Treat·2006
8-other
The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
PMID 16467002·Cancer Invest·2006
8-other
Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer.
PMID 16203655·Cancer Invest·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1500 EAST MEDICAL CENTER DR, B1 FLOOR CANCER & GERIATRICS CTR RECP B
ANN ARBOR, MI 48109 - Phone
- (734) 936-6000
Quick Facts
- NPI
- 1225109242
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile